Arphio welcomes David Olafsson as their Chief Financial Officer

13.11.2023

Arphio is thrilled to announce the appointment of David Olafsson as their interim Chief Financial Officer.

David Olafsson brings a wealth of financial expertise and strategic leadership to Arphio. With an illustrious career in the finance sector, David Olafsson has a proven track record of steering financial growth, developing innovative strategies, and fostering corporate success.

"We are delighted to welcome David Olafsson to our leadership team at Arphio. With his extensive experience and profound financial acumen, we are confident he will play a pivotal role in propelling Arphio's growth and financial strategies," remarked Dr. Shlomo Sadoun, CEO of Arphio.

Arphio has been at the forefront of developing and providing vital treatments for rare diseases. The appointment of David Olafsson stands as a testament to the company's commitment to securing top-tier talent to drive innovation, growth, and continued success.

Partner up now!

At Arphio, our mission is to make treatments for rare diseases accessible to a wide international population. Get in touch today.

tarun.chawla@arphio.com - Business Development
istvan.tisler@arphio.com - Portfolio

Disclaimer: Products which are subject to patent protection are currently not offered or made available in countries where patents are in force.